Finding 560493 (2024-002)

Material Weakness
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-05-15
Audit: 356401
Auditor: Artesian CPA LLC

AI Summary

  • Core Issue: The Organization lacks formal documentation for cash management controls.
  • Impacted Requirements: Federal award recipients must report accurate cash management information and maintain effective controls.
  • Recommended Follow-Up: Implement a documented internal control process for cash management reviews.

Finding Text

Finding 2024-002: Material Weakness, Internal Control Over Compliance, Cash Management Criteria: A recipient of federal award is required to report information to the federal agency and is required to ensure there are controls in place over cash management. Condition and Context: The Organization did not have a formally documented control in place to ensure all cash management processes were completed accurately. Cause: The related review of cash management controls were not documented. Effect or Potential Effect: Without sufficient documentation and monitoring controls, the Organization may not be able to detect an error in cash management on a timely basis. Recommendation: We recommend the Organization establish and follow a documented internal control process over review of cash management.

Corrective Action Plan

Responsible Official’s Response: Management agrees with the recommendation to establish and follow a documented internal control process over the review of cash management. Staff will work to develop an appropriate internal control process and once the process has been developed staff will document in writing, the process and review it with department leaders. Additionally, staff members working in areas concerning this process will be trained to ensure process adherence.

Categories

Subrecipient Monitoring Cash Management Material Weakness Internal Control / Segregation of Duties

Other Findings in this Audit

  • 1136935 2024-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.399 Cancer Control $1.01M